Of the donors, 12.5% suffered from an additional liver disease, 17.5% from a chronic inflammatory disease, 12.5% patients had diabetes mellitus and 5% of patients used CYP2C19 inhibitors before surgery. Here, CYP2C19 is linked to liver disorder.